Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute oxaliplatin-induced peripheral nerve hyperexcitability.

Richard H Wilson1, Tanya Lehky, Rebecca R Thomas

  • 1Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|March 29, 2002
PubMed
Summary

Oxaliplatin causes acute, reversible neurotoxicity characterized by peripheral nerve hyperexcitability. Carbamazepine did not relieve these symptoms, highlighting the need for neuroprotective strategies in cancer patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The circadian gene Dec2 promotes pancreatic cancer progression and dormancy through immune evasion.

Developmental cell·2026
Same author

Clinical and Genetic Characteristics of Free Sialic Acid Storage Disorder.

Journal of inherited metabolic disease·2026
Same author

Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament Analyses.

Muscle & nerve·2026
Same author

Utilization of a Deep Learning Algorithm for Automated Segmentation of Median Nerve from Ultrasound Obtained from the Distal Forearm and Wrist.

Bioengineering (Basel, Switzerland)·2025
Same author

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Nature·2025
Same author

Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment.

Annals of neurology·2025

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Oxaliplatin is a platinum compound used in cancer treatment.
  • Neurotoxicity is a significant dose-limiting side effect of oxaliplatin.
  • Oxaliplatin-induced neurotoxicity presents as acute and chronic forms.

Purpose of the Study:

  • To investigate the neurotoxicity of oxaliplatin in cancer patients.
  • To characterize the acute neurologic symptoms and electrophysiologic changes associated with oxaliplatin.
  • To evaluate the efficacy of carbamazepine in mitigating oxaliplatin-induced neurotoxicity.

Main Methods:

  • A Phase I study was conducted to determine the maximum-tolerated dose of capecitabine with oxaliplatin.
  • Detailed neurologic examinations, electromyography (EMG), and nerve conduction studies (NCS) were performed on a subset of patients.

Related Experiment Videos

  • Carbamazepine was administered to assess its effect on neurotoxicity in additional patients.

    • Main Results:

    • All patients experienced acute, reversible neurotoxicities, including paresthesias and cold hypersensitivity.
    • EMG and NCS revealed significant motor nerve hyperexcitability following oxaliplatin administration.
    • Carbamazepine treatment did not alter the observed clinical or electromyographic abnormalities.

    Conclusions:

    • Acute oxaliplatin neurotoxicity is linked to peripheral nerve hyperexcitability, resembling neuromyotonia.
    • Carbamazepine was ineffective in relieving the neurologic symptoms or electrophysiologic changes.
    • Developing neuroprotective strategies is crucial for improving patient quality of life and enabling full oxaliplatin dosing.